Hormone replacement therapy [topp]
Risk [qlco]
Venous Thromboembolism [patf]
postmenopausal [tmco]
Women [popg]
Review, Systematic [inpr]
Meta-Analysis [inpr]
Objective [inpr]
Assess [acty]
Risk [qlco]
Venous Thromboembolism [patf]
Women [popg]
Using [ftcn]
Hormone replacement therapy [topp]
Study Design [resa]
Characteristics [qlco]
therapy [ftcn]
Venous Thromboembolism [patf]
Clinical [qlco]
Background [cnce]
Design [acty]
Review, Systematic [inpr]
Meta-Analysis [inpr]
Data Sources [qnco]
MEDLINE [inpr]
Study [mnob]
reviewed [inpr]
Eight [qnco]
Observational Study [resa]
Nine [qnco]
Controlled [ftcn]
Trial [resa]
Inclusion Criteria [qlco]
Study [mnob]
Hormone replacement therapy [topp]
Reported [inpr]
Venous Thromboembolism [patf]
Review [inpr]
Measure [qnco]
Homogeneity [qlco]
studies [lbpr]
Using [ftcn]
I- [inch]
Statistics [ocdi]
Overall [inpr]
Risk [qlco]
Venous Thromboembolism [patf]
Assessed [acty]
Fixed [fndg]
effects [qlco]
RANDOM [resa]
Effect [qlco]
Model [inpr]
Result [ftcn]
Meta-Analysis [inpr]
Observational Study [resa]
Show [inpr]
Oral [spco]
Estrogen [horm, phsu, strd]
Not [ftcn]
transdermal estrogen [horm, phsu, strd]
Increased [qnco]
Risk [qlco]
Venous Thromboembolism [patf]
Compared [acty]
Non [ftcn]
Users [humn]
Estrogen [horm, phsu, strd]
Odds Ratio [qnco]
First [qnco]
Time [tmco]
Venous Thromboembolism [patf]
Current [tmco]
Users [humn]
Oral [spco]
Estrogen [horm, phsu, strd]
Confidence Interval [qnco]
Current [tmco]
Users [humn]
transdermal estrogen [horm, phsu, strd]
Past [tmco]
Users [humn]
Oral [spco]
Estrogen [horm, phsu, strd]
Similar [qlco]
Risk [qlco]
Venous Thromboembolism [patf]
Never [tmco]
Users [humn]
Risk [qlco]
Venous Thromboembolism [patf]
Women [popg]
Using [ftcn]
Oral [spco]
Estrogen [horm, phsu, strd]
High [qlco]
First [qnco]
treatment [ftcn]
Compared [acty]
treatment [ftcn]
More [ftcn]
One [qnco]
P NOS [aapp, imft]
Risk [qlco]
Venous Thromboembolism [patf]
Observed [ftcn]
Oral [spco]
Estrogen [horm, phsu, strd]
Oral [spco]
Estrogen [horm, phsu, strd]
Result [ftcn]
Nine [qnco]
Controlled [ftcn]
Trial [resa]
confirmed [qlco]
Increased [qnco]
Risk [qlco]
Venous Thromboembolism [patf]
Women [popg]
Using [ftcn]
Oral [spco]
Estrogen [horm, phsu, strd]
Combination [qlco]
Oral [spco]
Estrogen [horm, phsu, strd]
Mutations [genf]
Obesity [dsyn]
Further [spco]
Enhanced [acty]
Risk [qlco]
Venous Thromboembolism [patf]
transdermal estrogen [horm, phsu, strd]
Not [ftcn]
To [qlco]
Additional [ftcn]
Risk [qlco]
Women [popg]
High Risk [qlco]
Venous Thromboembolism [patf]
Conclusion [idcn]
Oral [spco]
Estrogen [horm, phsu, strd]
Increase [ftcn]
Risk [qlco]
Venous Thromboembolism [patf]
First [qnco]
treatment [ftcn]
transdermal estrogen [horm, phsu, strd]
Safeties [hcpp]
Risk [qlco]
More [ftcn]
Data [idcn]
Required [ftcn]
To [qlco]
investigate [ftcn]
Risk [qlco]
Wide [spco]
Variety [cnce]
Hormone [horm]
regimens [inpr]
Different [qlco]
Types [qlco]
Progestogens [horm, phsu, strd]
